vimarsana.com

Page 18 - கலைக்கழகம் ஆஃப் இராணுவம் மருத்துவ அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China starts building vaccine plant – The Manila Times

BEIJING: The nation’s first mRNA coronavirus disease 2019 (Covid-19) vaccine production plant will be built in Yuxi, Southwest China’s Yunnan Province, which is expected to produce 120 million doses of vaccines annually after the plant is completed. The mRNA vaccine, called ARcoVax, is being co-developed by the Academy of Military Medical Sciences, Suzhou ABOGEN and Yunnan Walvax Biotechnology Co. An employee at Walvax told the Global Times that a groundbreaking ceremony was held on Monday. The share price of Walvax surged 5 percent following the release of the information. “The mRNA vaccine requires high-standard production techniques, and only a few companies in Germany and US have the core technology,” said Li Yunchun, chairman of Walvax.

China starts building COVID-19 vaccine production facility - China News

2020-12-21 12:36:12 GMT2020-12-21 20:36:12(Beijing Time) Xinhua English KUNMING, Dec. 21 (Xinhua) China started the construction on Monday of a plant for manufacturing an mRNA-based COVID-19 vaccine, with production operations due to begin in eight months, according to local authorities. The facility in the city of Yuxi, in southwest China s Yunnan Province, is expected to produce 120 million doses per year in its first phase, with key manufacturing equipment and core ingredients all independently developed by China. The vaccine was approved by the National Medical Products Administration for clinical drug trials on June 19, 2020, and is about to enter phase-II clinical trials.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.